Search Results - "Abildgaard, C F"

Refine Results
  1. 1
  2. 2

    Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors by Lusher, Jeanne M, Arkin, Steven, Abildgaard, Charles F, Schwartz, Richard S

    Published in The New England journal of medicine (18-02-1993)
    “…Despite improved methods of viral attenuation of plasma-derived clotting-factor concentrates in recent years, the transmission of certain blood-borne viruses…”
    Get full text
    Journal Article
  3. 3

    Immune Status of Human Immunodeficiency Virus Seropositive and Seronegative Hemophiliacs Infused for 3.5 Years With Recombinant Factor VIII by Mannucci, P.M., Brettler, D.B., Aledort, L.M., Lusher, J.M., Abildgaard, C.F., Schwartz, R.S., Hurst, D.

    Published in Blood (01-04-1994)
    “…Recent studies suggest that treatment of hemophiliacs with highly purified factor VIII concentrates may preserve immune function. To test this hypothesis, we…”
    Get full text
    Journal Article
  4. 4

    Medical management of extensive spinal epidural hematoma in a child with factor IX deficiency by Sheikh, A A, Abildgaard, C F

    Published in Pediatric emergency care (01-02-1994)
    “…We report an unusual case of extensive spinal epidural hematoma in a seven-year-old male with severe factor IX deficiency. Despite evidence of extensive spinal…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Age and human immunodeficiency virus infection in persons with hemophilia in California by Holman, R C, Gomperts, E D, Jason, J M, Abildgaard, C F, Zelasky, M T, Evatt, B L

    Published in American journal of public health (1971) (01-08-1990)
    “…Thirteen hemophilia centers provide comprehensive care to approximately 90 percent of persons with hemophilia in California. For 1987, these centers reported…”
    Get full text
    Journal Article
  7. 7

    Fibrinolytic and hemostatic changes during and after maximal exercise in males by Davis, G L, Abildgaard, C F, Bernauer, E M, Britton, M

    Published in Journal of applied physiology (1948) (01-03-1976)
    “…To evaluate changes in fibrinolytic activity, factor VIII and other hematological variables during and after a progressive step increment in work load, 10…”
    Get more information
    Journal Article
  8. 8

    Serial Studies in von Willebrand's Disease: Variability Versus “Variants” by Abildgaard, Charles F., Suzuki, Zeko, Harrison, Janet, Jefcoat, Kathryn, Zimmerman, Theodore S.

    Published in Blood (01-10-1980)
    “…The variability of laboratory findings in von Willebrand's disease (vWd) was evaluated by performing serial studies of bleeding time (BT), factor VIII…”
    Get full text
    Journal Article
  9. 9

    von Willebrand factor multimer analysis using a sensitive peroxidase staining method by Tomita, Y, Harrison, J, Abildgaard, C F

    Published in Thrombosis and haemostasis (1989)
    “…A peroxidase staining method for von Willebrand factor (vWF) multimer analysis was modified for comparison with an autoradiographic method. This method…”
    Get more information
    Journal Article
  10. 10

    Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy by SEREMETIS, LUSHER, ABILDGAARD, KASPER, ALLRED, HURST

    “…Fifty‐eight previously treated haemophilic subjects were treated exclusively with the recombinant FVIII (rFVIII‐KOGENATE®) produced by Bayer Corporation…”
    Get full text
    Journal Article
  11. 11

    Anti-inhibitor Coagulant Complex (Autoplex) for treatment of factor VIII inhibitors in hemophilia by Abildgaard, CF, Penner, JA, Watson-Williams, EJ

    Published in Blood (01-12-1980)
    “…Fourteen individuals with severe hemophilia complicated by factor VIII inhibitors (1 to 132 Bethesda Units) were treated for 33 bleeding episodes with a new…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Fletcher Factor Deficiency: Family Study and Detection by Abildgaard, Charles F., Harrison, Janet

    Published in Blood (01-05-1974)
    “…Eight of 11 children of a known Fletcher factor-deficient individual were found to have normal activated partial thromboplastin times, normal levels of factors…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Lack of von Willebrand factor, factor VIII related antigen and factor VIII coagulant response to human growth hormone infusion in type 2 diabetes mellitus by Grecu, E O, Sheikholislam, B M, Abildgaard, C F

    “…Excessive growth hormone (GH) secretion and platelet hyperaggregation have been considered to be involved in the development of the vascular complications of…”
    Get more information
    Journal Article
  17. 17

    A New Variant of Dominant Type II von Willebrand's Disease With Aberrant Multimeric Pattern of Factor VIII-Related Antigen (Type HD) by Kinoshita, Seiji, Harrison, Janet, Lazerson, Jack, Abildgaard, Charles F.

    Published in Blood (01-06-1984)
    “…A new type II variant form of von Willebrand's disease has been recognized in a mother and daughter who have bleeding manifestations typical of von…”
    Get full text
    Journal Article
  18. 18

    Acquired von Willebrand's Syndrome in Systemic Lupus Erythematosus by Simone, Joseph V., Cornet, Jo Ann, Abildgaard, Charles F.

    Published in Blood (01-06-1968)
    “…A boy is described with clinical and laboratory manifestations which were indistinguishable from von Willebrand’s disease. However, the relatively recent onset…”
    Get full text
    Journal Article
  19. 19

    Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura by Woerner, S J, Abildgaard, C F, French, B N

    Published in Pediatrics (Evanston) (01-04-1981)
    “…Intracranial hemorrhage is a rare but life-threatening complication of childhood idiopathic thrombocytopenic purpura. We present three cases of this…”
    Get full text
    Journal Article
  20. 20